0001415889-22-005252.txt : 20220518
0001415889-22-005252.hdr.sgml : 20220518
20220518180225
ACCESSION NUMBER: 0001415889-22-005252
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220518
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Straube Richard
CENTRAL INDEX KEY: 0001595197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 22940589
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE, SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4-05182022_030516.xml
X0306
4
2022-05-18
0000812796
SOLIGENIX, INC.
SNGX
0001595197
Straube Richard
C/O SOLIGENIX, INC.
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
false
true
false
false
SENIOR VICE PRESIDENT AND CMO
COMMON STOCK
2022-05-18
4
P
0
8000
0.5000
A
8000
D
/s/ Richard C. Straube
2022-05-18